drugset
drugset / Trial / NCT04242407

Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty

NCT04242407 ↗

Phase 2 Unknown 164 enrolled Teikoku Pharma USA, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to evaluate the analgesic efficacy of Dexmedetomidine Transdermal System (DMTS), compared with placebo, in participants following abdominoplasty.

Timeline

Start
2020-07-07
Primary completion
2021-02-01
Completion
2021-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified — Other

Indications

neuropathy, painful